Cargando…

PTC124 Rescues Nonsense Mutation of Two Tumor Suppressor Genes NOTCH1 and FAT1 to Repress HNSCC Cell Proliferation

(1) Background: PTC124 (Ataluren) is an investigational drug for the treatment of nonsense mutation-mediated genetic diseases. With the exception of the TP53 tumor suppressor gene, there has been little research on cancers with nonsense mutation. By conducting a database search, we found that anothe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Ming-Han, Lu, Rui-Yu, Yu, Si-Jie, Tsai, Yi-Zhen, Lin, Ying-Chen, Bai, Zhi-Yu, Liao, Ruo-Yu, Hsu, Yi-Chiang, Chen, Chia-Chi, Cai, Bi-He
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9687978/ https://www.ncbi.nlm.nih.gov/pubmed/36428516 http://dx.doi.org/10.3390/biomedicines10112948

Ejemplares similares

Aminoglycosides, but not PTC124 (Ataluren), rescue nonsense mutations in the leptin receptor and in luciferase reporter genes
por: Bolze, Florian, et al.
Publicado: (2017)

A Simple and Affordable Method to Create Nonsense Mutation Clones of p53 for Studying the Premature Termination Codon Readthrough Activity of PTC124
por: Chen, Chia-Chi, et al.
Publicado: (2023)

Use of PTC124 for nonsense suppression therapy targeting BMP4 nonsense variants in vitro and the bmp4(st72) allele in zebrafish
por: Krall, Max, et al.
Publicado: (2019)

A comparative evaluation of NB30, NB54 and PTC124 in translational read-through efficacy for treatment of an USH1C nonsense mutation
por: Goldmann, Tobias, et al.
Publicado: (2012)

NAMPT Inhibitor and P73 Activator Represses P53 R175H Mutated HNSCC Cell Proliferation in a Synergistic Manner
por: Cai, Bi-He, et al.
Publicado: (2022)

MARVELD1 Inhibits Nonsense-Mediated RNA Decay by Repressing Serine Phosphorylation of UPF1
por: Hu, Jianran, et al.
Publicado: (2013)

NOTCH1 Intracellular Domain and the Tumor Microenvironment as Prognostic Markers in HNSCC
por: Schmidl, Benedikt, et al.
Publicado: (2022)

Targeting Nonsense: Optimization of 1,2,4-Oxadiazole TRIDs to Rescue CFTR Expression and Functionality in Cystic Fibrosis Cell Model Systems
por: Pibiri, Ivana, et al.
Publicado: (2020)

High NOTCH1 mRNA Expression Is Associated with Better Survival in HNSCC
por: Wirth, Markus, et al.
Publicado: (2018)

Repression of tumor suppressor miR-451 is essential for NOTCH1-induced oncogenesis in T-ALL
por: Li, Xiaoyu, et al.
Publicado: (2011)

The effect of PTC124 on choroideremia fibroblasts and iPSC-derived RPE raises considerations for therapy
por: Torriano, Simona, et al.
Publicado: (2018)

MAD-X PTC Integration
por: Schmidt, Frank, et al.
Publicado: (2005)

Synergistic Rescue of Nonsense Mutant Tumor Suppressor p53 by Combination Treatment with Aminoglycosides and Mdm2 Inhibitors
por: Zhang, Meiqiongzi, et al.
Publicado: (2018)

Investigation of PTC124-mediated translational readthrough in a retinal organoid model of AIPL1-associated Leber congenital amaurosis
por: Leung, Amy, et al.
Publicado: (2022)

Rescue of nonsense mutations by amlexanox in human cells
por: Gonzalez-Hilarion, Sara, et al.
Publicado: (2012)

3D renal modeling classifies BHD as a ciliopathy, possibly responsive to treatment with PTC124
por: Basten, S, et al.
Publicado: (2012)

SOX1 Functions as a Tumor Suppressor by Repressing HES1 in Lung Cancer
por: Chang, Shan-Yueh, et al.
Publicado: (2023)

The Tumor Suppressor Role of miR-124 in Osteosarcoma
por: Geng, Shuo, et al.
Publicado: (2014)

CRISPR-Pass: Gene Rescue of Nonsense Mutations Using Adenine Base Editors
por: Lee, Choongil, et al.
Publicado: (2019)

Targeting translational read-through of premature termination mutations in BMPR2 with PTC124 for pulmonary arterial hypertension
por: Long, Lu, et al.
Publicado: (2020)

MicroRNA-mediated repression of nonsense mRNAs
por: Zhao, Ya, et al.
Publicado: (2014)

FAM64A promotes HNSCC tumorigenesis by mediating transcriptional autoregulation of FOXM1
por: Zhao, Xinyuan, et al.
Publicado: (2022)

NUMB enhances Notch signaling by repressing ubiquitination of NOTCH1 intracellular domain
por: Luo, Zhiyuan, et al.
Publicado: (2019)

Retraction: The Tumor Suppressor Role of miR-124 in Osteosarcoma
por: Geng, Shuo, et al.
Publicado: (2019)

Genetic Explanations: Sense and Nonsense
por: Chen, Jiin-Yu
Publicado: (2014)

Therapeutic promise of engineered nonsense suppressor tRNAs
por: Porter, Joseph J., et al.
Publicado: (2021)

MUC1 confers radioresistance in head and neck squamous cell carcinoma (HNSCC) cells
por: Huang, Tian-qiao, et al.
Publicado: (2020)

Stop codons and the +4 nucleotide may influence the efficiency of G418 in rescuing nonsense mutations of the HERG gene
por: Yu, Haiyun, et al.
Publicado: (2019)

IL-8 promotes HNSCC progression on CXCR1/2-meidated NOD1/RIP2 signaling pathway
por: Chan, Leong-Perng, et al.
Publicado: (2016)

PP2C phosphatases Ptc1 and Ptc2 dephosphorylate PGK1 to regulate autophagy and aflatoxin synthesis in the pathogenic fungus Aspergillus flavus
por: Zhu, Zhuo, et al.
Publicado: (2023)

LINC00173 regulates polycystic ovarian syndrome progression by promoting apoptosis and repressing proliferation in ovarian granulosa cells via the microRNA-124-3p (miR-124-3p)/jagged canonical Notch ligand 1 (JAG1) pathway
por: Chen, Lan, et al.
Publicado: (2022)

A study to evaluate association of nuclear grooving in benign thyroid lesions with RET/PTC1 and RET/PTC3 gene translocation
por: Ashwini, Basavaraj Rangalakshmi, et al.
Publicado: (2023)

Sestrin1, a tumor suppressor that can be rescued
por: Donaldson, Maria C., et al.
Publicado: (2017)

A Lack of Premature Termination Codon Read-Through Efficacy of PTC124 (Ataluren) in a Diverse Array of Reporter Assays
por: McElroy, Stuart P., et al.
Publicado: (2013)

Suppression of Nonsense Mutations by New Emerging Technologies
por: Morais, Pedro, et al.
Publicado: (2020)

miR-124 Functions As A Melanoma Tumor Suppressor By Targeting RACK1
por: Shen, Congcong, et al.
Publicado: (2019)

Rational design of an orthogonal tryptophanyl nonsense suppressor tRNA
por: Hughes, Randall A., et al.
Publicado: (2010)

1H-1,2,4-Triazole-3-carboxamide
por: Xie, Qing-Ruo
Publicado: (2008)

CHD4 Predicts Aggressiveness in PTC Patients and Promotes Cancer Stemness and EMT in PTC Cells
por: Pratheeshkumar, Poyil, et al.
Publicado: (2021)

Radiation exposure, young age, and female gender are associated with high prevalence of RET/PTC1 and RET/PTC3 in papillary thyroid cancer: a meta-analysis
por: Su, Xuan, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_gcbhqrmh5gc1r4h7g3pdumcdp2